MiNK Therapeutics Inc. (INKT)
NASDAQ: INKT
· Real-Time Price · USD
15.02
-0.44 (-2.85%)
At close: Oct 03, 2025, 3:59 PM
14.50
-3.43%
After-hours: Oct 03, 2025, 07:06 PM EDT
MiNK Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.77B | 3.77B | 3.77B | -11.71B | -11.71B | -11.71B | n/a | 14.41B | 15.98B | 17.54B | 5.83B | 3.34B | 1.78B | 221.92M | 221.92M | n/a | n/a | n/a |
Cost of Revenue | 1.88B | 1.88B | 1.88B | 1.88B | 5.22B | 11.57B | 17.42B | 17.42B | 20.18B | 21.54B | 23.06B | 23.06B | 28.45B | 20.75B | 13.38B | 13.38B | 16.19K | 16.19K |
Gross Profit | -597 | 3.07K | n/a | -13.59B | -16.93B | -23.28B | -17.42B | -3.01B | -4.21B | -4B | -17.23B | -19.72B | -26.67B | -20.53B | -13.15B | -13.38B | -16.19K | -16.19K |
Operating Income | -10.61M | -9.99M | -11.29M | -14.29M | -17.62M | -20.9M | -22.92M | -25.31M | -28.07M | -29.43M | -30.95M | -29.42M | -34.81M | -32.72M | -28.36M | -23.52M | -16.07M | -14.13M |
Interest Income | 131.45K | 169.47K | 172.57K | 174.52K | 203.79K | 311.82K | 463.26K | 556.57K | 542.24K | 395.85K | 227.79K | 92.96K | n/a | n/a | n/a | n/a | n/a | 557.55K |
Pretax Income | -11.27M | -9.74M | -10.78M | -13.78M | -17.09M | -20.59M | -22.46M | -24.77M | -25.98M | -25.9M | -27.99M | -25.99M | -33.92M | -34.14M | -30.21M | -25.98M | -17.76M | -15.75M |
Net Income | -2.78B | -2.77B | -10.78M | -13.78M | -17.09M | -20.59M | 145.76M | 143.73M | 144.27M | 145.96M | -24.75M | -23.03M | -32.71M | -34.55M | -30.21M | -25.98M | -17.76M | -15.75M |
Selling & General & Admin | 1.27B | 1.27B | 4.31M | 5.64M | 6.27M | 7M | 7.38M | 7.32M | 7.36M | 7.4M | 7.83M | 8.12M | 7.1M | 6.14M | 4.64M | 1.97M | 1.62M | 1.32M |
Research & Development | 1.27B | 1.27B | 6.34M | 8.24M | 11.13M | 13.85M | 15.49M | 17.99M | 20.71M | 22.03M | 23.12M | 21.25M | 18.44M | 16.15M | 13.97M | 10.8M | 9.97M | 9.5M |
Other Expenses | -2.53B | -2.53B | 638.05K | 404.03K | 223.09K | 53.68K | 53.68K | -15.37K | 1.55M | 3.11M | 2.7M | 2.72M | -8.43M | -9.99M | -9.59M | -9.59M | n/a | n/a |
Operating Expenses | 10.73M | 10.16M | 11.29M | 14.29M | 17.62M | 20.9M | 22.92M | 25.31M | 28.07M | 29.43M | 30.95M | 29.37M | 25.53M | 22.29M | 18.61M | 12.77M | 11.6M | 10.92M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 160.36K | 160.36K | 186.74K | 187.59K | 28.77K | 910.1K | 1.69M | 2.43M | 3.12M | 2.87M | 2.07M |
Selling & Marketing Expenses | n/a | n/a | n/a | -54.04K | -54.04K | -54.04K | -54.04K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.78M | 10.16M | 11.29M | 14.29M | 17.62M | 20.9M | 22.92M | 25.31M | 28.07M | 29.43M | 30.95M | 29.37M | 25.53M | 22.29M | 18.61M | 12.77M | 11.6M | 10.92M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -168.22M | -168.5M | -170.25M | -171.86M | -3.24M | -2.96M | -1.21M | 404.36K | 1.55K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.98M | 3.96M | 3.77M | 3.74M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M | 3.4M | 3.38M | 3.38M | 3.36M | 3.35M | 3.29M | 3.29M | 2.84M | 2.84M |
Shares Outstanding (Diluted) | 3.98M | 3.96M | 3.77M | 3.95M | 3.71M | 3.46M | 3.46M | 3.45M | 3.44M | 3.4M | 3.38M | 3.38M | 3.36M | 3.35M | 3.29M | 3.29M | 2.84M | 2.84M |
EPS (Basic) | -2.89 | -2.56 | -2.96 | -3.89 | -4.89 | -5.96 | 43.04 | 42.42 | 42.50 | 43.00 | -7.3 | -6.9 | -9.8 | -10.7 | -9.7 | -8.44 | -6.24 | -5.84 |
EPS (Diluted) | -2.87 | -2.54 | -2.94 | -3.87 | -4.89 | -5.96 | 43.04 | 42.42 | 42.50 | 43.00 | -7.3 | -6.9 | -9.8 | -10.7 | -9.7 | -8.44 | -6.24 | -5.84 |
EBITDA | -10.89M | -9.56M | -10.62M | -13.9M | -17.25M | -20.68M | -22.72M | -25.12M | -27.91M | -29.29M | -30.83M | -28.72M | -34.12M | -32.05M | -27.79M | -22.88M | -14.9M | -12.97M |
EBIT | -11.1M | -9.77M | -10.83M | -14.12M | -17.46M | -20.9M | -22.92M | -25.31M | -28.07M | -29.43M | -30.95M | -28.82M | -34.21M | -32.13M | -27.85M | -22.94M | -14.97M | -13.03M |
Depreciation & Amortization | 216.03K | 212.37K | 215.44K | 215.14K | 205.96K | 212.76K | 204.62K | 188.98K | 163.96K | 140.36K | 121.75K | 107.65K | 99.5K | 88.84K | 77.96K | 70.26K | 64.81K | 59.21K |